The Merlin CP-GEP Test, validated in the largest prospective gene expression profiling study in melanoma ( MERLIN_001 ), demonstrated that a High-Risk result identifies patients with a threefold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback